《“使用家庭配送皮下注射呋塞米治疗慢性肾脏病心力衰竭患者急性液体超负荷（WCN24 - 813）”的勘误》[第9卷，第4期，增刊，2024年4月，第S251 - S252页]
Corrigendum to "WCN24-813 MANAGEMENT OF ACUTE FLUID OVERLOAD IN HEART FAILURE PATIENTS WITH CKD USING HOME DELIVERED SUBCUTANEOUS FUROSEMIDE" [ Volume 9, Issue 4, Supplement, April 2024, Page S251-S252].
作者信息
Montero Rosa, Anenden Ashwin, Nokes Jane, Gnanapragasam Vasa, Ali Mahrukh, Hussain Sabba, Chung Isaac, Sunter Matthew, Bijman Laura, Williams Tristan, Annear Nicholas, Ster Irina Chis, Anderson Lisa, Banerjee Debasish
机构信息
Renal medicine, St George's University Hospital NHS Foundation Trust, London.
Hospital At Home, Central London Community Healthcare NHS Trust, London.
出版信息
Kidney Int Rep. 2024 Jul 5;9(9):2837. doi: 10.1016/j.ekir.2024.07.001. eCollection 2024 Sep.
Abstract
[This corrects the article DOI: 10.1016/j.ekir.2024.02.515.].
摘要
[本文更正了文章的数字对象标识符：10.1016/j.ekir.2024.02.515。]
相似文献
1
Corrigendum to "WCN24-813 MANAGEMENT OF ACUTE FLUID OVERLOAD IN HEART FAILURE PATIENTS WITH CKD USING HOME DELIVERED SUBCUTANEOUS FUROSEMIDE" [ Volume 9, Issue 4, Supplement, April 2024, Page S251-S252].《“使用家庭配送皮下注射呋塞米治疗慢性肾脏病心力衰竭患者急性液体超负荷（WCN24 - 813）”的勘误》[第9卷，第4期，增刊，2024年4月，第S251 - S252页]
Kidney Int Rep. 2024 Jul 5;9(9):2837. doi: 10.1016/j.ekir.2024.07.001. eCollection 2024 Sep.
2
Corrigendum to "WCN24-1051 CLINICAL PROFILE, DIAGNOSIS, THERAPEUTIC INTERVENTION AND COMPLICATIONS IN RENAL BIOPSY IN CKD POPULATION - SINGLE CENTER 20 YEARS' EXPERIENCE" [ Volume 9, Issue 4, Supplement, April 2024, Page S86].《慢性肾脏病患者肾活检的临床特征、诊断、治疗干预及并发症——单中心20年经验》勘误[第9卷，第4期，增刊，2024年4月，第S86页]
Kidney Int Rep. 2024 May 23;9(7):2312-2313. doi: 10.1016/j.ekir.2024.05.019. eCollection 2024 Jul.
3
Corrigendum to "WCN24-1675 ACUTE NECROTIZING ULCERATIVE GENGIVITIS IN KIDNEY TRANSPLANTATION: A CASE REPORT" [ Volume 9, Issue 4, Supplement, April 2024, Page S473].《肾移植中的急性坏死性溃疡性龈炎：一例报告》勘误 [第9卷，第4期，增刊，2024年4月，第S473页]
Kidney Int Rep. 2024 Apr 19;9(6):1937-1938. doi: 10.1016/j.ekir.2024.04.037. eCollection 2024 Jun.
4
Corrigendum to "WCN24-2216 Clinical-surgical parameters in patients with arteriovenous fistulas failure in SERMESA'S nephrological centers during 2022" [ Volume 9, Issue 4, Supplement, April 2024, Page S411].《“2022年SERMESA肾脏病中心动静脉内瘘失败患者的临床手术参数”勘误》[第9卷，第4期，增刊，2024年4月，第S411页]
Kidney Int Rep. 2024 Apr 18;9(6):1940-1942. doi: 10.1016/j.ekir.2024.04.035. eCollection 2024 Jun.
5
Corrigendum to "WCN24-2021 KNOWLEDGE ATTITUDES AND BELIEFS ABOUT KIDNEY TRANSPLANTATION IN JAMAICAN RESIDENTS" [ Volume 9, Issue 4, Supplement, April 2024, Page S482].《牙买加居民对肾移植的知识、态度和信念》勘误 [第9卷，第4期，增刊，2024年4月，第S482页]
Kidney Int Rep. 2024 Jun 8;9(8):2582-2583. doi: 10.1016/j.ekir.2024.06.011. eCollection 2024 Aug.
6
Corrigendum to "WCN24-2499 CAVEOLIN-1 AND CAVEOLIN-2 AS POTENTIAL URINARY EARLY BIOMARKERS OF RENAL INJURY IN ACUTE CHOLESTASIS IN RATS" [ Volume 9, Issue 4, Supplement, April 2024, Page S541].《“WCN24 - 2499 小窝蛋白 - 1 和小窝蛋白 - 2 作为大鼠急性胆汁淤积性肾损伤潜在尿液早期生物标志物”的勘误》[第9卷，第4期，增刊，2024年4月，第S541页]
Kidney Int Rep. 2024 Jun 8;9(8):2583-2584. doi: 10.1016/j.ekir.2024.06.012. eCollection 2024 Aug.
7
Corrigendum to "WCN24-843 ULTRAPROCESSED FOODS: DETERMINANTS AND RELATIONSHIP WITH BIOCHEMICAL PARAMETERS IN CHRONIC HEMODIALYSIS PATIENTS" [ Volume 9, Issue 4, Supplement, April 2024, Page S371].《“WCN24 - 843 超加工食品：慢性血液透析患者的决定因素及其与生化参数的关系”勘误》[第9卷，第4期，增刊，2024年4月，第S371页]
Kidney Int Rep. 2024 Apr 18;9(6):1939. doi: 10.1016/j.ekir.2024.04.036. eCollection 2024 Jun.
8
Corrigendum to "WCN24-1065 QUALITY INDICATORS IN PERITONEAL DIALYSIS IN A CLINIC FROM FLORIANÓPOLIS, SANTA CATARINA, BRAZIL" [ Volume 9, Issue 4, Supplement, April 2024, Page S586].对《巴西圣卡塔琳娜州弗洛里亚诺波利斯一家诊所腹膜透析的质量指标》的勘误[第9卷，第4期，增刊，2024年4月，第S586页]
Kidney Int Rep. 2024 Apr 18;9(6):1943. doi: 10.1016/j.ekir.2024.04.033. eCollection 2024 Jun.
9
Corrigendum to "WCN24-1105 PHARMACOGENETIC RISK FACTORS FOR TENOFOVIR-INDUCED KIDNEY TUBULAR DYSFUNCTION AMONG HIV-POSITIVE ADULT NIGERIANS" [ Volume 9, Issue 4, Supplement, April 2024, Page S339].《“WCN24 - 1105 尼日利亚成年 HIV 感染者中替诺福韦诱导的肾小管功能障碍的药物遗传学风险因素”勘误》[第 9 卷，第 4 期，增刊，2024 年 4 月，第 S339 页]
Kidney Int Rep. 2024 May 17;9(7):2313-2314. doi: 10.1016/j.ekir.2024.05.018. eCollection 2024 Jul.
10
Corrigendum to "WCN24-1267 EMPAGLIFLOZIN IMPROVES VITALITY AND PROTECT FROM ADVANCED GLYCATION END PRODUCTS IN ENDOTHELIAL CELLS" [ Volume 9, Issue 4, Supplement, April 2024, Page S637].《WCN24 - 1267 恩格列净改善内皮细胞活力并保护其免受晚期糖基化终末产物影响》勘误 [第9卷，第4期，增刊，2024年4月，第S637页]
Kidney Int Rep. 2024 Apr 29;9(7):2311. doi: 10.1016/j.ekir.2024.04.052. eCollection 2024 Jul.
Zotero 插件